Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial. (Q47720040)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Björn Holzhauer

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Salman H Siddiqui

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Chris Brightling

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Amisha Singapuri

4

object named as

Amisha Singapuri

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Michelle Bourne

9

object named as

Michelle Bourne

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

10

object named as

Vijay Mistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5

object named as

Ruth Hartley

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

object named as

Sherif Gonem

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

12

object named as

Adel H Mansur

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Marie F M Laurencin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Gerald Bacher

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Richard A Kay

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

5 August 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

699-707

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Asthma phenotypes: the evolution from clinical to molecular approaches

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab and exacerbations of refractory eosinophilic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lebrikizumab treatment in adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dupilumab in persistent asthma with elevated eosinophil levels

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a questionnaire to measure asthma control.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a standardized version of the Asthma Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging roles of DP and CRTH2 in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930179-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-2600(16)30179-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27503237%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47720040&oldid=1744239545"